Supplementing with exogenous glutathione can lead to imbalances in these tightly controlled systems, potentially disrupting natural synthesis pathways and metabolic homeostasis
Lancet Diabetes Endocrinol 6(4):275286
Recent clinical evidence suggests that GLP-1 receptor agonist medicationsthe same class used in Ozempiccan address both the metabolic and hormonal components of PCOS by reducing insulin resistance, supporting sustainable weight loss, and potentially improving ovulation patterns
The entry of generic oral semaglutide reflects a broader shift where regulatory science, local clinical evidence, and patent strategy are converging to influence market access in high-value therapies
Healthcare professionals are likewise being reminded to prescribe only FDA-approved treatments and to educate patients about the dangers of unregulated drugs
The manufacturer focuses on biotechnological research & sterile peptide formulations